{"id":280331,"date":"2026-09-30T11:24:01","date_gmt":"2026-09-30T05:54:01","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=280331"},"modified":"2026-09-30T11:24:01","modified_gmt":"2026-09-30T05:54:01","slug":"hospital-stocks-fall-supreme-court-drug-margin","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/hospital-stocks-fall-supreme-court-drug-margin\/","title":{"rendered":"Hospital Stocks Fall Up to 7%: Why Max, Apollo and Fortis Are Sliding After Supreme Court’s 16% Drug Margin Remark"},"content":{"rendered":"

Max Healthcare down 6.8% at day low. Fortis down 6.05%. Apollo down 5.62%. SC suggests 16% margin on medicines. Next hearing 12 Oct 2026. Data as of 11 AM, 30 Sep.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Hospital stocks fell up to 7% on 30 September 2026 after the Supreme Court criticised 10-fold markups on cancer drugs sold by private hospitals and suggested a uniform 16% margin on all medicines. Max Healthcare, Fortis Healthcare and Apollo Hospitals were among the worst hit. The suggestion is not yet a ruling, and the court will hear the matter again on 12 October 2026. The worry is that any cap could cut into hospital pharmacy profits, a key earnings driver.<\/p>\n<\/div>\n

Hospital stocks came under heavy selling on Wednesday. Max Healthcare Institute fell as much as 6.78% to Rs 915.50 on the NSE, Fortis Healthcare slid up to 6.05% to Rs 772.30 and Apollo Hospitals Enterprise dropped up to 5.62% to Rs 8,172. Around 11 AM, all three were still down between 4.1% and 5.3%.<\/p>\n

The selling in hospital stocks was not limited to the big three. HealthCare Global Enterprises and Narayana Hrudayalaya also traded lower. The trigger was a pointed Supreme Court hearing on drug pricing held a day earlier.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n